BIOGEN INC. Current Liabilities 2008-2026 | BIIB
Beta
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is BIOGEN INC.'s current current liabilities?
BIOGEN INC. (BIIB) annual current liabilities for 2025 was $3.35B, a 39.42% decline from 2024. BIOGEN INC. current liabilities for the quarter ending March 31, 2026 was $3.00B.
What was BIOGEN INC.'s current liabilities in 2024?
BIOGEN INC. annual current liabilities for 2024 was $5.53B, a 60.99% increase from 2023.
What was BIOGEN INC.'s current liabilities in 2023?
BIOGEN INC. annual current liabilities for 2023 was $3.43B, a 4.93% increase from 2022.
What is BIOGEN INC.'s 5-year current liabilities CAGR?
BIOGEN INC. current liabilities grew at a compound annual growth rate (CAGR) of 2.19% from FY2020 to FY2025, going from $3.74B to $3.35B over 5 years.
Current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-2.2%
FY2020
$3.74B
→
FY2025
$3.35B
080910111213141516171819202122232425
5 years selected
Current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.35B | -39.4% | 10-K |
| FY2024 | $5.53B | +61.0% | 10-K |
| FY2023 | $3.43B | +4.9% | 10-K |
| FY2022 | $3.27B | -23.9% | 10-K |
| FY2021 | $4.30B | +14.9% | 10-K |
| FY2020 | $3.74B | -23.1% | 10-K |
| FY2019 | $4.86B | +47.6% | 10-K |
| FY2018 | $3.30B | -2.2% | 10-K |
| FY2017 | $3.37B | -1.5% | 10-K |
| FY2016 | $3.42B | +32.7% | 10-K |
| FY2015 | $2.58B | +16.2% | 10-K |
| FY2014 | $2.22B | +26.2% | 10-K |
| FY2013 | $1.76B | +6.1% | 10-K |
| FY2012 | $1.66B | +81.6% | 10-K |
| FY2011 | $912.9M | -13.1% | 10-K |
| FY2010 | $1.05B | +46.9% | 10-K |
| FY2009 | $714.9M | -22.6% | 10-K |
| FY2008 | $923.2M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →